Mohs RC, Shiovitz TM, Tariot PN, Porsteinsson AP, Baker KD, Feldman PD (2009) <br />Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study<br /><i>American Journal of Geriatry & Psychiatry</i> <b>17</b>: 752<br /><br />Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001) <br />Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology<br /><i>Neurology</i> <b>56</b>: 1154<br /><br />Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V (1999) <br />Cholinergic markers in elderly patients with early signs of Alzheimer disease [see comments]<br /><i>Jama</i> <b>281</b>: 1401<br /><br />Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998) <br />Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group<br /><i>Archives of Internal Medicine</i> <b>158</b>: 1021<br /><br />Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL (1995) <br />L-deprenyl and physostigmine for the treatment of Alzheimer's disease<br /><i>Psychiatry Research</i> <b>58</b>: 181<br /><br />Davis KL, Mohs RC (1986) <br />Cholinergic drugs in Alzheimer's disease<br /><i>N Engl J Med</i> <b>315</b>: 1286<br /><br />Johns CA, Mohs RC, Hollander E, Davis BM, Greenwald BS, Davidson M, Horvath TB, Davis KL (1986) <br />Clinical Studies of the Cholinergic Deficit in Alzheimers Disease<br /><i>Advances in Behavioral Biology</i> <b>30</b>: 133<br /><br />Davis BM, Mohs RC, Greenwald BS, Mathe AA, Johns CA, Horvath TB, Davis KL (1985) <br />Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies<br /><i>J Am Geriatr Soc</i> <b>33</b>: 741<br /><br />Mohs RC, Davis KL (1985) <br />Interaction of choline and scopolamine in human memory<br /><i>Life Sciences</i> <b>37</b>: 193<br /><br />Davis KL, Hsieh JY, Levy MI, Horvath TB, Davis BM, Mohs RC (1982) <br />Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type<br /><i>Psychopharmacol Bull</i> <b>18</b>: 193<br /><br />Davis KL, Mohs RC, Davis BM, Rosenberg GS, Horvath TH, DeNigris Y (1981) <br />Cholinomimetic Agents and Human Memory: Preliminary Observations in Alzheimers Disease<br /><i>Advances in Behavioral Biology</i> <b>25</b>: 929<br /><br />Mohs RC, Davis KL, Tinklenberg JR, Hollister LE (1980) <br />Choline chloride effects on memory in the elderly<br /><i>Neurobiology of Aging</i> <b>1</b>: 21<br /><br />Mohs RC, Davis KL, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS (1979) <br />Choline chloride treatment of memory deficits in the elderly<br /><i>Am J Psychiatry</i> <b>136</b>: 1275<br /><br />Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS (1978) <br />Physostigmine: improvement of long-term memory processes in normal humans<br /><i>Science</i> <b>201</b>: 272<br /><br />